⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

DHR

Danaher Corporation

Healthcare · Diagnostics & Research

204.85USD

-0.3800 (-0.19%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 204.85
P/E36.0
Dvd Ind Yld0.8%
P/B2.74
P/S5.7
Curr EV/T12M EBITDA28.4
Mkt Cap (USD)144.0B
Curr EV (USD)167.8B
2)

Per Share Data

EPS T12M5.62
DPS1.36
Bk Val Per Sh74.81
Rev/Sh35.48
Cash/Sh6.19
Curr Shares Out703.0M
FCF/Sh7.72
3)

Cash Flow Analysis

P/CF21.7
Curr P/FCF26.3
CF/NI1.7
Dvd P/O24.1%
Cash Gen/Cash Reqd3.1
Csh Dvd Cov6.9
CFO/Sales26.4%
Eff Interest Rate1.3%
4)

Growth Potential

Dil EPS 1Y Gr-4.5%
Cap 1Y Gr8.2%
BPS 1Y Gr9.2%
R&D To Sales6.4%
Retention Rate75.9%
Rev 1Y Gr2.9%
FCF 1Y Gr-0.7%
Assets 1Y Gr7.6%
5)

Profitability

EBITDA5.9B
EBIT5.1B
Operating Margin20.4%
Pretax Margin19.0%
Net Margin15.9%
ROA4.6%
ROE7.6%
ROC5.4%
Asset Turnover0.29
6)

Structure

Current Ratio1.65
Quick Ratio1.15
Debt/Assets28.8%
Debt/Com Eq50.5%
Net Debt/EBITDA3.54
Tot Debt/Capital33.6%
Gross Margin58.5%
EBIT/Int Exp17.6

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.